Squarepoint’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-153,465
| Closed | -$936K | – | 2977 |
|
|
2021
Q3 | $936K | Buy |
153,465
+55,793
| +57% | +$340K | ﹤0.01% | 1104 |
|
|
2021
Q2 | $804K | Buy |
97,672
+50,049
| +105% | +$412K | ﹤0.01% | 1325 |
|
|
2021
Q1 | $426K | Buy |
47,623
+30,671
| +181% | +$274K | ﹤0.01% | 1645 |
|
|
2020
Q4 | $196K | Sell |
16,952
-63,289
| -79% | -$732K | ﹤0.01% | 2148 |
|
|
2020
Q3 | $835K | Buy |
80,241
+19,086
| +31% | +$199K | 0.01% | 1031 |
|
|
2020
Q2 | $804K | Buy |
61,155
+20,112
| +49% | +$264K | 0.01% | 1054 |
|
|
2020
Q1 | $323K | Buy |
41,043
+1,987
| +5% | +$15.6K | 0.01% | 1261 |
|
|
2019
Q4 | $808K | Buy |
+39,056
| New | +$808K | ﹤0.01% | 1438 |
|
|
2019
Q3 | – | Sell |
-35,071
| Closed | -$431K | – | 2667 |
|
|
2019
Q2 | $431K | Sell |
35,071
-856
| -2% | -$10.5K | ﹤0.01% | 1704 |
|
|
2019
Q1 | $448K | Buy |
35,927
+23,144
| +181% | +$289K | ﹤0.01% | 1520 |
|
|
2018
Q4 | $145K | Sell |
12,783
-35,043
| -73% | -$397K | ﹤0.01% | 1743 |
|
|
2018
Q3 | $895K | Sell |
47,826
-22,876
| -32% | -$428K | 0.01% | 1042 |
|
|
2018
Q2 | $1.83M | Buy |
70,702
+50,172
| +244% | +$1.3M | 0.02% | 672 |
|
|
2018
Q1 | $460K | Buy |
+20,530
| New | +$460K | 0.01% | 1120 |
|
|
2017
Q4 | – | Sell |
-12,325
| Closed | -$298K | – | 2407 |
|
|
2017
Q3 | $298K | Buy |
+12,325
| New | +$298K | 0.01% | 1172 |
|
|
2017
Q1 | – | Sell |
-47,033
| Closed | -$895K | – | 2045 |
|
|
2016
Q4 | $895K | Buy |
+47,033
| New | +$895K | 0.04% | 554 |
|
|
2016
Q3 | – | Sell |
-24,500
| Closed | -$367K | – | 1352 |
|
|
2016
Q2 | $367K | Buy |
+24,500
| New | +$367K | 0.02% | 657 |
|